Open AccessPlasma DNA Analysis in Prostate Cancer: Opportunities for Improving Clinical Management
Author(s) -
Anjui Wu,
Gerhardt Attard
Publication year - 2018
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2018.287250
Subject(s) - prostate cancer , liquid biopsy , biomarker , medicine , cancer , biomarker discovery , metastasis , disease , prostate , management of prostate cancer , biopsy , oncology , computational biology , pathology , bioinformatics , biology , gene , biochemistry , proteomics
Molecular characterization of tumors could be important for clinical management. Plasma DNA obtained noninvasively as a liquid biopsy could be widely applicable for clinical implementation in biomarker-based treatment strategies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom